uniQure Announces Upcoming Presentation of Data at Annual

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
uniQure Announces Upcoming Presentation of Data at Annual American Society of Hematology Meeting

– Poster presentation on Saturday, December 3, 2016 –

– Investor breakfast event on Monday, December 5 at 7:00 am PST/10:00 am EST –

LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Nov. 03, 2016 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leader in human gene therapy, today announced that clinical data from a Phase I/II dose-escalating study of AMT-060, its investigational gene therapy in adult patients with severe hemophilia B, will be presented at the 58 th American Society of Hematology (ASH) Annual Meeting, held in San Diego, CA from December 3 to 6, 2016.

Updated data on AMT-060 will be presented by study investigator Professor Frank W.G. Leebeek, M.D. Ph.D. of the Erasmus Medical Center in Rotterdam, the Netherlands. AMT-060 is an AAV5-FIX gene therapy developed by uniQure using its proprietary insect-cell based technology platform. The updated data will include up to 52 weeks of follow-up on the first patient cohort receiving 5x10 12 gc/kg and up to 26 weeks of follow-up on the second patient cohort receiving a higher dose of 2x10 13 gc/kg.

The conference abstract is available today and can be accessed at http://www.hematology.org/Annual-Meeting . The abstract includes previously reported data of up to nine months from the first patient cohort in the study.

“We will present updated clinical data at ASH on long-term durability of FIX activity now out to one year,” stated Christian Meyer, M.D., Ph.D., chief medical officer of uniQure.  “We also will present the additional shift in disease phenotype through data from the second, higher-dose cohort, and an update on previously reported results that demonstrate that four out of five patients no longer require chronic infusions of prophylaxis.  We look forward to Professor Leebeek’s presentation and to hosting an investor event at the meeting.”

Poster Presentation

Title: Interim results from a dose escalating study of AMT-060 (AAV5-hFIX) gene transfer in adult patients with severe hemophilia B
Presenter: Professor Frank W.G. Leebeek, M.D. Ph.D.
Poster Session: 801. Gene Therapy and Transfer: Poster I
Date and Time: Saturday, December 3, 2016, 5:30 pm PST/8:30 pm EST
Location: Hall GH, San Diego Convention Center 

Investor and Analyst Breakfast and Webcast

uniQure management will host an investor breakfast meeting featuring Professor Leebeek to review the updated data on AMT-060 and outline progress taking place with its ongoing clinical development.  The meeting will be webcast live along with slides and can be accessed by visiting the investor relations section of the Company’s website at www.uniQure.com

Date and Time: Monday, December 5, 2016 at 7:00 am PST/ 10:00 am EST
Location: Marriott Gaslamp Hotel, Room Presidio A, 660 K Street, San Diego, CA 92101

To request attendance at the meeting, please RSVP to Investors@uniQure.com by November 30, 2016, as space is limited.

A replay of the investor event will be available on the uniQure website, approximately three hours after the presentation and will be archived on the site for at least 30 days.

AMT-060 Phase I/II Trial Overview

The Phase I/II, open-label, multi-center study includes 10 patients each receiving a one-time, 30-minute, intravenous administration of AMT-060, without the use of immunosuppression therapy. The study includes two dose cohorts of five patients each, with the first cohort receiving 5x10 12 gc/kg and the second cohort receiving 2x10 13 gc/kg.  All patients in the trial had documented severe or moderately-severe hemophilia, including documented FIX levels less than 1-2%, and required chronic infusions of prophylactic or on-demand Factor IX therapy at the time of enrolment. uniQure will follow all 10 patients in the study for a period of five years to further assess long-term safety and durability.

About Hemophilia B

Hemophilia B is a serious and rare inherited disease in males characterized by insufficient blood clotting.  The condition can lead to repeated and sometimes life-threatening episodes of external and internal bleeding following accidental trauma or medical interventions.  The episodes can cause long-term damage, for example to the joints, and can be fatal if they occur in the brain.  The deficient blood clotting results from the lack of functional human Factor IX, or hFIX. Treatment of hemophilia B today consists of prophylactic or on-demand protein replacement therapy, in which frequent intravenous administrations of plasma-derived or recombinant hFIX are required to stop or prevent bleeding. Hemophilia B occurs in approximately 1 out of 30,000 live births.

About uniQure

uniQure is delivering on the promise of gene therapy – single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with CNS, liver/metabolic and cardiovascular diseases. www.uniQure.com

uniQure Forward-Looking Statement

This press release contains forward-looking statements. All statements other than statements of historical fact are forward-looking statements, which are often indicated by terms such as "anticipate," "believe," "could," "estimate," "expect," "goal," "intend," "look forward to", "may," "plan," "potential," "predict," "project," "should," "will," "would" and similar expressions. Forward-looking statements are based on management's beliefs and assumptions and on information available to management only as of the date of this press release. These forward-looking statements include, but are not limited to, statements regarding the development of our gene therapies, the success of our collaborations, and the risk of cessation, delay or lack of success of any of our ongoing or planned clinical studies and/or development of our product candidates. Our actual results could differ materially from those anticipated in these forward-looking statements for many reasons, including, without limitation, risks associated with collaboration arrangements, our and our collaborators’ clinical development activities, regulatory oversight, product commercialization and intellectual property claims, as well as the risks, uncertainties and other factors described under the heading "Risk Factors" in uniQure’s 2015 Annual Report on Form 20-F filed with the Securities and Exchange Commission on April 4, 2016. Given these risks, uncertainties and other factors, you should not place undue reliance on these forward-looking statements, and we assume no obligation to update these forward-looking statements, even if new information becomes available in the future.

uniQure Contacts:  
   
Maria E. Cantor Tom Malone
Direct: 339-970-7536 Direct:  339-970-7558
Mobile:  617-680-9452 Mobile:  339-223-8541
m.cantor@uniQure.com  t.malone@uniQure.com
   
   
Eva M. Mulder  
Direct:  +31 20 240 6103  
Mobile: +31 6 52 33 15 79   
e.mulder@uniQure.com   
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Mike Blyth’s Hall of Fame Honors a Builder’s Legacy

Updated Category News Views 147

Recognition earned in the hangar, not a boardroom Aircraft design has a ruthless way of exposing empty talk, which is why Mike Blyth’s November 11 induction into the EAA Homebuilders Hall of Fame carries real weight. The Experimental Aircraft Association’s honor, presented in the Eagle Hangar at the EAA Aviation Museum in Oshkosh, Wisconsin, recognizes a career built...

Continue Reading
New Flight Charters Puts a Cap on Winter Surprises

Updated Category News Views 115

Ice on a wing is routine; ice on an invoice is where charter customers start muttering. New Flight Charters says it will again absorb de-icing and hangar charges this winter, up to $2,500 per trip, marking the seventh consecutive season for the program. In a business where the headline quote can look tidy and the final bill can arrive wearing muddy boots, that is a...

Continue Reading
AES Clears FERC, Nearing Its December 2 Takeover Close

Updated Category News Views 50

One more regulatory gate just swung open for AES, and this deal is finally staring at the finish line instead of wandering through the usual approval swamp. The Federal Energy Regulatory Commission has issued its final order approving AES's acquisition by a consortium led by Global Infrastructure Partners, part of BlackRock, and EQT Infrastructure VI. The last major...

Continue Reading
DEFSEC Tackles Nasdaq Bid Price Hurdle with Share Move

Updated Category News Views 13

Navigating Bid Price Deficiency Issues Well, it seems DEFSEC Technologies Inc. found themselves in a tricky spot last week. A nasty gram from Nasdaq’s Listing Qualifications Department pointing out that DEFSEC's shares had dipped below that $1.00 per share requirement for too long—a full 30 business days. Now, don't panic just yet. This isn't about the shares getting...

Continue Reading
Philadelphia Firm Targets 100 Toys for Children This Holiday

Updated Category News Views 139

A hundred unopened toys can look modest on paper, yet that is exactly why this Philadelphia effort lands differently than the usual chest-thumping corporate charity chatter. van der Veen, Hartshorn & Levin has set a clear holiday target: collect 100 new, unwrapped toys for children in the Philadelphia area through the U.S. Marine Corps Reserve Toys for Tots program. No...

Continue Reading
Avelo Tests Loyalty Math With WeSalute Fare Discounts

Updated Category News Views 115

Airline discounts can look like generosity until the load factor starts talking back. Avelo Airlines has joined WeSalute with fare discounts for active-duty military members, veterans, first responders, nurses, medical professionals, public servants, teachers and eligible family members. It is a sensible move for a young carrier built around smaller airports and lower...

Continue Reading
Norris Lake's New Kayak Fleet Propels Tourism Efforts

Updated Category News Views 217

Norris Lake Doubles Down on Water Adventures The winds of change are paddling through Norris Dam State Park as they've launched a new fleet of shiny kayaks, hoping to lure more adventure seekers into the heart of Tennessee. These ain't just boats; they're part of a bigger play by local tourism honchos hungry to pump some adrenaline—and dollars—back into the area. A...

Continue Reading
A Faded Sign Is a Quiet Leak in Storefront Demand Today

Updated Category News Views 72

Sunlight does not care what the marketing budget said. A storefront can have a decent product, a clean interior and a capable crew, then lose the first impression before anyone reaches the door because its sign looks tired. That is the plainspoken point behind FASTSIGNS' latest guidance on outdoor sign lifespan. This is not glamorous stuff, but it is operationally...

Continue Reading
MobileX's $10 Plan Puts Holiday Pressure on Wireless

Updated Category News Views 110

A sixty-dollar commitment is a small bet, but in wireless it can become a loud little nuisance for every carrier charging far more. MobileX has rolled out a Black Friday offer giving new customers 10GB of high-speed data, unlimited talk and text, and six months of service for $60 upfront. That pencils out to $10 a month, before taxes and government surcharges, and it runs...

Continue Reading
Makers Nutrition Credit Puts a Clock on New Brands

Updated Category News Views 141

A few cents per bottle can look downright beautiful when a new supplement brand is staring at its first production bill. Makers Nutrition announced on November 17 a Black Friday manufacturing-credit offer aimed at entrepreneurs and established sellers launching a new formulation, with qualifying new orders eligible for as much as $0.45 per unit through November 29, 2026....

Continue Reading

Top 5 Most Recently Viewed Articles

Riyadh Gears Up for UNIDO 2025: A Step Towards Sustainable Industry

Updated Category News Views 180

Riyadh Gears Up for UNIDO 2025 Riyadh is on the verge of an exciting global event as it prepares to host the 21st Session of the United Nations Industrial Development Organization (UNIDO) General Conference. This significant summit is scheduled to happen at the King Abdulaziz International Conference Centre, where leaders from various sectors will gather to discuss the...

Continue Reading
Deer Park Road Strategizes for Growth Amid CRE Market Changes

Updated Category News Views 205

Deer Park Road Strategies in a Changing CRE Landscape Deer Park Road Management Company, LP, a notable $2.8 billion alternative asset management firm, is honing in on emerging prospects within the challenging environment of the Commercial Mortgage-Backed Securities (CMBS) market. The firm’s extensive expertise enables them to consistently identify potential value during...

Continue Reading
iRobot Corporation Faces Legal Challenges Amid Financial Struggles

Updated Category News Views 141

Legal Investigations into iRobot Corporation Investors are currently facing uncertainties surrounding iRobot Corporation as it faces legal scrutiny. The well-respected law firm Faruqi & Faruqi, LLP has initiated investigations regarding potential legal claims on behalf of investors who suffered significant losses. Who to Contact James (Josh) Wilson, a partner at Faruqi &...

Continue Reading
Dr. Andrea Fuyuko Honda Recognized for Medical Innovation Excellence

Updated Category News Views 385

Dr. Andrea Fuyuko Honda's Recent Recognition Dr. Andrea Fuyuko Honda has been prominently recognized as a Pinnacle Professional Member within an elite circle of excellence. This accolade reflects her significant contributions to the field as a Leading Medical Communications Expert and Innovator. With a career spanning over fifteen years, Dr. Honda has demonstrated...

Continue Reading
Centene Corporation Faces Securities Fraud Legal Action

Updated Category News Views 206

Centene Corporation Faces New Lawsuit Over Securities Fraud Investors of Centene Corporation, known by the ticker symbol CNC, have found themselves at the center of a securities fraud lawsuit. Recently, a leading law firm announced the initiation of legal action against Centene Corporation and some of its senior executives. This lawsuit stems from alleged violations of...

Continue Reading